-
公开(公告)号：US10286047B2
公开(公告)日：2019-05-14
申请号：US14773020
申请日：2014-03-07
申请人： UNIVERSITÄT BERN , CSL BEHRING GMBH
摘要： The present invention relates to a contact activation system inhibitor, preferably a C1INH, for use in the treatment and/or prevention of remote ischemia-reperfusion injury (IRI), comprising administering the contact activation system inhibitory to an individual.
-
公开(公告)号：US10232015B2
公开(公告)日：2019-03-19
申请号：US15622447
申请日：2017-06-14
申请人： CSL Behring GmbH
发明人： Stefan Schulte , Rolf Spirig , Sabine Zollner , Michael Moses , Wilfried Wormsbaecher , Hans-Arnold Stoehr
IPC分类号： A61K38/17 , A61K31/7016 , A61K31/7008 , A61K31/70 , A61K31/7004
摘要： The invention relates to compositions comprising an isolated sugar for use in the treatment of von Willebrand disease and/or hemophilia A, wherein the sugar is an accessible sugar residue derived from ABO(H) blood group antigen.
-
公开(公告)号：US09707269B2
公开(公告)日：2017-07-18
申请号：US14399326
申请日：2013-03-15
申请人： CSL Behring GmbH
发明人： Stefan Schulte , Rolf Spirig , Sabine Zollner , Michael Moses , Wilfried Wormsbaecher , Hans-Arnold Stoehr
IPC分类号： A61K38/17 , A61K31/7004 , A61K31/7016 , A61K31/70 , A61K31/7008
CPC分类号： A61K38/1709 , A61K31/70 , A61K31/7004 , A61K31/7008 , A61K31/7016
摘要： The invention relates to compositions comprising an isolated sugar for use in the treatment of von Willebrand disease and/or hemophilia A, wherein the sugar is an accessible sugar residue derived from ABO(H) blood group antigen.
-
公开(公告)号：US10973891B2
公开(公告)日：2021-04-13
申请号：US16359598
申请日：2019-03-20
IPC分类号： C07K14/745 , A61K38/36 , A61P7/04 , A61K38/57 , A61K45/06
摘要： The present invention relates to a contact activation system inhibitor, preferably a C1INH, for use in the treatment and/or prevention of remote ischemia-reperfusion injury (IRI), comprising administering the contact activation system inhibitory to an individual.
-
5.发明申请Sugar Compositions for Treating Hemophilia A and/or Von Willebrand Disease 有权用于治疗血友病A和/或Von Willebrand疾病的糖组合物公开(公告)号：US20150087592A1
公开(公告)日：2015-03-26
申请号：US14399326
申请日：2013-03-15
申请人： CSL Behring GmbH
发明人： Stefan Schulte , Rolf Spirig , Sabine Zollner , Michael Moses , Wilfried Wormsbaecher , Hans-Arnold Stoehr
IPC分类号： A61K38/17 , A61K31/7004 , A61K31/7016
CPC分类号： A61K38/1709 , A61K31/70 , A61K31/7004 , A61K31/7008 , A61K31/7016
摘要： The invention relates to compositions comprising an isolated sugar for use in the treatment of von Willebrand disease and/or hemophilia A, wherein the sugar is an accessible sugar residue derived from ABO(H) blood group antigen.
摘要翻译： 本发明涉及包含用于治疗血管性血友病和/或血友病A的分离糖的组合物，其中糖是衍生自ABO（H）血型抗原的可接近的糖残基。
-
-
-
-
搜索结果
5 条记录 (耗时 0.027 秒)
